As agentic AI begins to reshape how decisions are made across commercial, market access, and post-launch functions, pharma faces a fundamental question: what does “patient-centricity” actually mean in practice in this new scenario?
Co-hosted by HLTH and Capgemini, this session moves beyond idealized narratives to explore how organizations are, balancing patient outcomes with revenue pressures, access constraints, and real-world trade-offs. We’ll examine how AI-driven decision-making is challenging traditional commercial roles, redefining operating models, and forcing more explicit choices about who and what sits at the center.
Expect a candid, business-focused and honest debate on how AI is exposing and reshaping the gap between aspiration and reality, and what that means for future commercial models.
Designed for senior decision-makers, this peer to peer roundtable discussion followed by a private networking reception, offers a forum to exchange insights, challenge assumptions, and shape the future of patient-centricity in this new AI world.
By applying to this event, you agree to our Terms and Privacy Notice.
